ERBB2 and breast carcinoma: In terms of pathological type, we used immunohistochemistry (IHC) including ER, PR, Her2 and Ki67 to type breast cancer in our study, subcohort: Luminal A-like, Luminal B-like, Her2-enriched and Triple-negative breast cancer (TNBC) (1, 8).